aTyr Pharma (LIFE) Announces Partner Kyorin Pharmaceutical, Co., Ltd. Proceeds to Phase 1 Trial of ATYR1923 in Japan

Go back to aTyr Pharma (LIFE) Announces Partner Kyorin Pharmaceutical, Co., Ltd. Proceeds to Phase 1 Trial of ATYR1923 in Japan
Life Technologies Corporation (NASDAQ: LIFE) Delayed: 36.00 -0.4 (1.1%)
Previous Close $36.40    52 Week High $10.93 
Open $36.89    52 Week Low $2.48 
Day High $38.00    P/E 13.28 
Day Low $35.34    EPS $2.71 
Volume 2,770,952